1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med.,2005
2. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma;Weller;J Clin Oncol.,2003
3. Chemotherapy for glioblastoma: is costly better?;Linz;Cancer.,2008
4. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol.,2009
5. Verleye L, Coens C, Amant F, et al. Extreme drug resistance for carboplatin predicts resistance to first-line therapy in advanced-stage ovarian cancer: results from the EORTC-CGC/NCIC-CTG neoadjuvant trial. Paper presented at: International Gynecologic Cancer Society 12th Biennial Meeting, Bangkok, Thailand, October 25-28, 2008.